Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Suntory reports new agents for circulatory disorders

Jan. 21, 1997

Sumitomo reports novel hCNTF variant

Jan. 21, 1997

Human IL-9 reported in patent literature

Jan. 21, 1997

Celltech reports new PDE IV inhibitors

Jan. 21, 1997

Merck & Co. claims NMDA and AMPA antagonists for neurologic indications

Jan. 21, 1997

New anticonvulsants from Howard University

Jan. 21, 1997

Shaman patents new antifungal agents

Jan. 21, 1997

Mochida claims new formulation for ulinastatin

Jan. 20, 1997

Takeda claims new approach to diabetes Rx

Jan. 20, 1997

New wound-healing agents reported

Jan. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...